CoChat

Decreased whole body lipolysis as a mechanism of the lipid-lowering effect of pioglitazone in type 2 diabetic patients

Gastaldelli, Amalia, Casolaro, Arturo, Ciociaro, Demetrio, Frascerra, Silvia, Nannipieri, Monica, Buzzigoli, Emma, Ferrannini, Ele · 2009 · American Journal of Physiology-Endocrinology and Metabolism
Cited by 36

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Pioglitazone has been shown to reduce fasting triglyceride levels. The mechanisms of this effect have not been fully elucidated, but decreased lipolysis may contribute to blunt the hypertriglyceridemic response to a meal. To test this hypothesis, we studied 27 type 2 diabetes mellitus (T2DM) patients and 7 sex-, age-, and body mass index-matched nondiabetic controls. Patients were randomized to pioglitazone (45 mg/day) or placebo for 16 wk. Whole body lipolysis was measured [as the [2 H 5]glycerol rate of appearance (R a)] in the fasting state and for 6 h following a mixed meal. Compared with controls, T2DM had higher postprandial profiles of plasma triglycerides, free fatty acid (FFA), and β-hydroxybutyrate, and a decreased suppression of glycerol R a( P < 0.04) despite higher insulin levels [268 (156) vs. 190 (123) pmol/l, median (interquartile range)]. Following pioglitazone, triglycerides and FFA were reduced ( P = 0.05 and P < 0.04, respectively), and glycerol R a was more suppressed [−40 (137) vs. +7 (202) μmol/min of placebo, P < 0.05] despite a greater fall in insulin [−85 (176) vs. −20 (58) pmol/l, P = 0.05]. We conclude that, in well-controlled T2DM patients, whole body lipolysis is insulin resistant, and pioglitazone improves the insulin sensitivity of lipolysis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1152/ajpendo.90960.2008

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 23

  1. 10.1007/s00125-005-0092-4 · DOI
  2. 10.2337/dc06-2558 · DOI · Paper page
  3. 10.2337/diacare.27.7.1660 · DOI · Paper page
  4. 10.1007/s00125-006-0560-5 · DOI
  5. 10.1172/JCI116544 · DOI · Paper page
  6. 10.2337/diab.36.11.1341 · DOI · Paper page
  7. 10.1038/sj.clpt.6100034 · DOI · Paper page
  8. 10.1152/jappl.1999.87.5.1813 · DOI · Paper page
  9. 10.1038/nm780 · DOI · Paper page
  10. 10.1152/ajpendo.1999.276.5.E863 · DOI · Paper page
  11. 10.2337/diabetes.49.5.677 · DOI · Paper page
  12. 10.1210/jcem.86.11.8027 · doi:10.1210/jcem.86.11.8027 · Paper page
  13. 10.1152/ajpendo.00662.2006 · DOI
  14. 10.2337/diabetes.50.5.1158 · DOI · Paper page
  15. 10.1161/ATVBAHA.107.150193 · DOI · Paper page
  16. Swislocki AL, Chen YD, Golay A, Chang MO, Reaven GM.Insulin suppression of plasma-free fatty acid concentration in normal individuals and patients with type 2 (non-insulin-dependent) diabetes.Diabetologia30: 622–626, 1987. · DOI
  17. 10.1038/nm0703-811 · DOI
  18. 10.1007/s00125-004-1619-9 · DOI
  19. 10.1016/S0026-0495(03)00106-9 · DOI
  20. 10.2337/diacare.28.4.844 · DOI · Paper page
  21. 10.1210/jc.2005-1073 · DOI
  22. 10.2337/diabetes.54.9.2720 · DOI · Paper page
  23. Wolfe R.Radioactive and Stable Isotope Tracers in Biomedicine. New York: Wiley-Liss, 1992. · DOI

Cited by

See all 36

Metadata

Authors
Gastaldelli, A., Casolaro, A., Ciociaro, D., Frascerra, S., Nannipieri, M., Buzzigoli, E., & Ferrannini, E.
Venue
American Journal of Physiology-Endocrinology and Metabolism
Published
2009-07
Volume
297
Issue
1
Pages
E225-E230
ISSN
  • 0193-1849 (ISSN-L)
  • 1522-1555
OpenAlex
W2100806174
Cited by
36
References
9
FWCI
0.72
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Decreased whole body lipolysis as a mechanism of the lipid-lowering effect of pioglitazone in type 2 diabetic patients. https://app.cochat.ai/papers/10.1152/ajpendo.90960.2008
The paper
Gastaldelli, A., Casolaro, A., Ciociaro, D., Frascerra, S., Nannipieri, M., Buzzigoli, E., & Ferrannini, E. (2009). Decreased whole body lipolysis as a mechanism of the lipid-lowering effect of pioglitazone in type 2 diabetic patients. American Journal of Physiology-Endocrinology and Metabolism. https://doi.org/10.1152/ajpendo.90960.2008

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.